The features of clinical and anamnestic indicators, cognitive function, quality of life, and psychological status in patients with various stages of chronic lower extremity ischemia

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To estimate the frequency of risk factors and the features of the psychosocial status in patients with atherosclerosis of the lower extremity arteries.

Subjects and methods. The investigation prospectively included 198 patients with atherosclerosis of the lower extremity arteries. The patients’ mean age was 67.9±8.0 years. Data copying, questioning, instrumental and analytical methods were used to study the patients’ clinical and anamnestic indicators. The survey was conducted using the SF-36 questionnaire and the SpielbergerKhanin test, Mini-Mental State Examination (MMSE), and Morisky-Green scales. Depending on the stage of ischemia, according to the Pokrovsky-Fontaine classification, the investigators formed two investigation groups: 1) 127 patients with Stage 0–IIA ischemia; 2) 71 patients with Stage IIB-IV ischemia.

Results. There was a male preponderance in both groups: 106 men in Group 1 (p=0.03) and 52 in Group 2 (p=0.026). The number of smokers was statistically significantly higher in Group 2 than in Group 1 (37.0 and 49.0%, respectively; p=0.05). No statistically significant differences in diabetes were found between the groups. Systolic blood pressure was also higher in Group 2 than in Group 1 (136.3±15.3 and 130.7±12.9 mm Hg, respectively; p=0.0015). Analysis of physical (p = 0.00019) and psychosocial (p=0.0415) states revealed lower rates in Group 2.

Conclusion. The findings suggest that Group 2 patients had more severe clinical, physical, and psychosocial conditions, which indicates the need to attract a psychologist for patients with more severe ischemia, as well as that to more carefully monitor hemodynamic parameters and to correct modifiable risk factors in both groups.

Full Text

Restricted Access

About the authors

S. Makarov

Research Institute for Complex Issues of Cardiovascular Diseases

Author for correspondence.
Email: Smirkv@kemcardio.ru

MD

Russian Federation, Kemerovo

K. Smirnov

Research Institute for Complex Issues of Cardiovascular Diseases

Email: Smirkv@kemcardio.ru
Russian Federation, Kemerovo

Ya. Danilchenko

Research Institute for Complex Issues of Cardiovascular Diseases

Email: Smirkv@kemcardio.ru

Candidate of Medical Sciences

Russian Federation, Kemerovo

References

  1. Cardiovascular diseases. World Health Organization (in Russ.). URL: https://www.who.int/ru/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
  2. Natsional’nye rekomendatsii po vedeniyu patsientov s sosudistoi arterial’noi patologiei. Chast’ 1 Perifericheskie arterii. M., 2010; 78 р. (in Russ.).
  3. Shval’b P.G., Kalinin R.E., Kachinskii A.E. Konservativnoe lechenie zabolevaniya perifericheskikh sosudov. Pod red. P.G. Shval’b, D.R. Rakita. Ryazan: Poligraf. kombinat «Tigel», 2008; 91 р. (in Russ.).
  4. Dormandy J.A., Rutherford R.B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000; 31 (1 Pt 2): S1–296.
  5. Smirnov K.V., Makarov S.A. Chronic obliterating diseases of the arteries of the lower extremities. Vrach. 2021; 32 (10): 28–35 (in Russ.). doi: 10.29296/25877305-2021-10-05
  6. Makarov S.A., Smirnov K.V. Features of the management of patients with atherosclerotic lesions of the arteries of the lower extremities at the outpatient stage. Complex problems of cardiovascular diseases. 2021; 10 (2S): 79–82 (in Russ.). doi: 10.17802/2306-1278-2021-10-2S-79-82
  7. Vasil'eva I.V. Psychodiagnostics: uchebnoe posobie. M.: Flinta, 2013; 252 р. (in Russ.).
  8. Barbarash N.A., Kuvshinov D.Y. Smoking and cardiovascular risk factors. Complex problems of cardiovascular diseases. 2016; 1: 51–4 (in Russ.). doi: 10.17802/2306-1278-2016-1-51-54
  9. Ostroumova O.D., Maximov M.L., Dralova O.V. et al. Hypertension and atherosclerosis: how to choose antihypertensive drugs? Difficult patient. 2013; 11 (7): 16–21 (in Russ.).
  10. Dedov D., Mukailov N., Evtyuxin I. The combination of amlodipine and atorvastatin in reducing the risk of cardiovascular complications. Vrach. 2013; 3: 18–9 (in Russ.).
  11. Kaplan M., Aviram M. Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase. Clin Chem Lab Med. 1999; 37 (8): 777–87. doi: 10.1515/CCLM.1999.118
  12. Izard K.E. Psychology of emotions. Transl. Engl. V. Misnik, A. Tatlybaeva. SPb: Peter, 2011; 460 р. (in Russ.).

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Systolic blood pressure in the investigation groups

Download (59KB)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies